Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 10441497)

Published in Biochem Biophys Res Commun on August 11, 1999

Authors

J Nezu1, A Oku, M Shimane

Author Affiliations

1: Chugai Research Institute for Molecular Medicine Inc., 153-2 Nagai Niihari, Ibaraki, 300-4101, Japan. nezuj@cimmed.com

Articles citing this

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J (2003) 3.62

Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells. Circulation (2008) 2.48

Somatic LKB1 mutations promote cervical cancer progression. PLoS One (2009) 2.21

Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci U S A (2002) 1.83

Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci U S A (2002) 1.67

STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell (2008) 1.54

LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology (2010) 1.47

Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol (2009) 1.41

Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem J (2003) 1.37

STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest (2010) 1.23

Regulation of LKB1/STRAD localization and function by E-cadherin. Curr Biol (2008) 1.18

Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab (2010) 1.12

Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell (2010) 1.10

LKB1, the multitasking tumour suppressor kinase. J Clin Pathol (2005) 1.07

LKB1 catalytic activity contributes to estrogen receptor alpha signaling. Mol Biol Cell (2009) 1.00

Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function. Int J Mol Sci (2014) 0.96

The LKB1 complex-AMPK pathway: the tree that hides the forest. Fam Cancer (2011) 0.95

Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics (2005) 0.93

LKB1 controls human bronchial epithelial morphogenesis through p114RhoGEF-dependent RhoA activation. Mol Cell Biol (2013) 0.91

Articles by these authors

Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem (1998) 2.05

Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am J Hum Genet (1998) 1.98

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun (2000) 1.76

Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics (1997) 1.75

A novel family of bromodomain genes. Genomics (2000) 1.72

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem (1998) 1.66

Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br J Pharmacol (2001) 1.61

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet (1999) 1.61

Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics (1997) 1.55

Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett (1997) 1.50

Identification and characterization of BRDT: A testis-specific gene related to the bromodomain genes RING3 and Drosophila fsh. Genomics (1997) 1.43

Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther (1999) 1.31

Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem (2000) 1.25

Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther (1999) 1.24

No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res (2000) 1.11

Identification and characterization of BPTF, a novel bromodomain transcription factor. Genomics (2000) 1.10

T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism (2000) 1.09

Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol (2001) 1.02

Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen. Exp Cell Res (1998) 1.00

Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab (2000) 0.99

Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring. J Med Chem (1999) 0.89

Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver. Biochem Biophys Res Commun (1999) 0.88

Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum Mutat (2000) 0.88

Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency. Blood (1994) 0.86

A marked decrease in defensin mRNA in the only case of congenital neutrophil-specific granule deficiency reported in Japan. Int J Hematol (1994) 0.86

Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF). J Immunol Methods (1989) 0.86

Normalization of cytoplasmic calcium response in pancreatic beta-cells of spontaneously diabetic GK rat by the treatment with T-1095, a specific inhibitor of renal Na+-glucose co-transporters. Horm Metab Res (2002) 0.85

Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis. Inflamm Res (1999) 0.83

Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant (1994) 0.81

Expression of granulocyte and granulocyte-macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors (1990) 0.81

Na(+)-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives based on a new concept. Chem Pharm Bull (Tokyo) (1996) 0.80

Chichibabin indolizine synthesis revisited: synthesis of indolizinones by solvolysis of 4-alkoxycarbonyl-3-oxotetrahydroquinolizinium ylides. J Org Chem (2001) 0.79

Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders. Br J Haematol (1996) 0.79

Phenotype-dependent expression of cadherin 6B in vascular and visceral smooth muscle cells. FEBS Lett (2000) 0.77

Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice. Hepatology (1999) 0.77

Asymmetric Mukaiyama-Michael addition of acyclic enones catalyzed by allo-threonine-derived B-aryloxazaborolidinones. Org Lett (2001) 0.76

Enantioselective ring cleavage of dioxane acetals mediated by a chiral Lewis acid: application to asymmetric desymmetrization of meso-1,3-diols. Org Lett (2001) 0.75

[A case of focal fatty liver associated with pregnancy toxemia]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75

[Microwave coagulation under ultrasound guidance in liver hemangioma]. Nihon Shokakibyo Gakkai Zasshi (1983) 0.75

Pathophysiological roles of G-CSF. J Nutr Sci Vitaminol (Tokyo) (1992) 0.75

[Epidemic hemorrhagic fever occurring in Wakayama Medical College: a clinical and laboratory study of 7 patients (author' transl)]. Kansenshogaku Zasshi (1981) 0.75

Endoscopic observation of upper gastrointestinal mucosal changes in chronic liver diseases. J Gastroenterol Hepatol (1989) 0.75

[High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)]. Rinsho Ketsueki (1993) 0.75

Tetrahydroquinolizinium ylides: preparation and 1,3-dipolar cycloaddition. J Org Chem (2001) 0.75

Pancreatic exocrine damage induced by subcutaneous injection of a low dosage of zinc. Biol Trace Elem Res (2001) 0.75

[A study of tumor markers in hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi (1984) 0.75

The production of granulocyte colony-stimulating factor and interleukin 6 by human bone marrow stromal cells in aplastic anemia. Tohoku J Exp Med (1993) 0.75

Primary fibrosarcoma of the liver with hypoglycemia. Acta Pathol Jpn (1983) 0.75